Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CEFEPIME vs CEFPODOXIME PROXETIL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CEFEPIME vs CEFPODOXIME PROXETIL: Safety Overview

Metric CEFEPIME CEFPODOXIME PROXETIL
Total FAERS Reports 5,540 323
Deaths Reported 997 5
Death Rate 18.0% 1.5%
Hospitalizations 3,055 160
Average Patient Age 56.5 yrs 52.9 yrs
% Female Patients 47.6% 70.0%
FDA Approval Date Aug 21, 2018 Aug 20, 2003
Manufacturer Apotex Corp. Amici Pharmaceuticals, LLC.
Route INTRAMUSCULAR ORAL
Marketing Status Discontinued Discontinued